Tissue engineering on matrix: future of autologous tissue replacement

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Cardiovascular Engineering

Background:

• Tissue engineering constructs living neo-tissues using biodegradable scaffolds.
• Scaffolds can be synthetic polymers or decellularized biological tissues.
• Autologous cells are seeded onto scaffolds for neo-tissue formation.

Purpose of the Study:

• To detail the process of creating functional cardiovascular constructs.
• To explain the role of conditioning in neo-tissue maturation.
• To highlight in vivo remodeling mechanisms and molecular control.

Main Methods:

• Fabrication of biodegradable scaffolds (synthetic or biological).
• Seeding scaffolds with autologous cells.
• Conditioning constructs using culture media and flow bioreactors.
• In vitro and in vivo assessment of neo-tissue formation and remodeling.

Main Results:

• Engineered constructs demonstrate cellular differentiation, proliferation, and extracellular matrix production.
• Conditioning promotes the formation of living autologous constructs (e.g., heart valves, vascular grafts).
• In vivo remodeling involves monocytic infiltration and inflammatory processes, guided by scaffold-integrated molecules.

Conclusions:

• Cardiovascular tissue engineering utilizes scaffolds and cell seeding for construct development.
• Biomimetic conditioning is crucial for in vitro maturation of engineered tissues.
• In vivo remodeling is a complex inflammatory process that can be modulated to enhance functional tissue integration.